NHS England to offer ‘potentially life-saving’ drug for aggressive breast cancer | Breast cancer

[ad_1] Women with a particularly aggressive form of breast cancer have been given access to a “potentially life-saving” drug after NHS bosses reached a deal with its manufacturer. Up to 1,600 women a year will be able to receive pembrolizumab, which has the potential to make some of those who take it completely cancer-free, NHS… Continue reading NHS England to offer ‘potentially life-saving’ drug for aggressive breast cancer | Breast cancer

Sanofi, Astra drug approved to protect infants from RSV in Europe

[ad_1] Sanofi and AstraZeneca Plc’s Beyfortus won European approval to protect babies from respiratory syncytial virus, a common infection that can turn deadly in young children. The European Commission became the first regulatory body to approve the antibody injection, clearing it for use in all newborns before their first RSV season, Sanofi said in a… Continue reading Sanofi, Astra drug approved to protect infants from RSV in Europe